Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07168148 · ClinicalTrials.gov registry record · Phase 2
Steroid Treatment for Elimination of Rebound Obstruction From Intranasal Decongestants
A Phase 2 study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT07168148 is a Phase 2 study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 3 participants.
The verdict
NCT07168148, a Phase 2 study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
This prospective, virtually administered trial conducted throughout the United States aims to evaluate a standardized protocol including the serial dilution of topical decongestants with concurrent topical steroids (triamcinolone), for elimination of dependence on topical decongestants.
Interventions
- DRUG Oxymetazoline + Triamcinolone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2025-11-10 |
| Est. Completion | 2026-03-19 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07168148
The ClinicalTrials.gov registry entry for NCT07168148 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oxymetazoline + Triamcinolone is the first listed.
NCT07168148 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07168148 about?
NCT07168148 is a clinical study titled "Steroid Treatment for Elimination of Rebound Obstruction From Intranasal Decongestants". This prospective, virtually administered trial conducted throughout the United States aims to evaluate a standardized protocol including the serial dilution of topical decongestants with concurrent topical steroids (triamcinolone), for elimination of dependence on topical decongestants.
What is the current status of trial NCT07168148?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2025-11-10. Estimated completion is 2026-03-19.
What interventions are being tested in trial NCT07168148?
The interventions under investigation include: Oxymetazoline + Triamcinolone (DRUG).
Who is sponsoring clinical trial NCT07168148?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.